Ultrasound guided saphenous and sciatic nerve block for leg surgery

Effect of nalbuphine on combined ultrasound guided sciatic and saphenous nerve block in orthopedic leg surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201603001532179

Enrollment

Registered

2016-03-11

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Orthopaedics Anaesthesia

Interventions

Placebo group

Bupivicaine group (B)

Nalbuphine group(N)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age between 15 - 40 years. Body Mass Index <30 kg/m2. American Society of Anesthesiology: I-II patients. No other fractures. Site of fracture: Leg

Exclusion criteria

Exclusion criteria: Patient refusal Patients with psychiatric diseases. American Society of Anesthesiology more than II . Opioid agonist or agonist/antagonist administration in the preceding 6 h (or within 1 h if given intravenously). Obesity (Body Mass Index > 30 kg/m2). History of bleeding tendency, cardiac ,respiratory, hepatic diseases and/or renal failures . Any contraindications to neuraxial block as infection at site of blockade, uncooperative patients, abnormal positions during operation. Multiple fractures.

Design outcomes

Primary

Measure	Time frame
The effect of combined saphenous and sciatic nerve block for intra and postoperative analgesia intraoperative and postoperative analgesia using VAS	—

Secondary

Measure	Time frame
the effect of nalbuphine on the blockade time	—

Countries

Egypt

Contacts

Public ContactIsmaeel Thoraya

Resident of Anesthesia and Surgical Intensive Care Mansoura University Hospitals

doctor_junior86@yahoo.com00201007332447

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026